
About SMPL
SMPL is a publicly listed company based in Pune (India) founded in 2001 by Vijay Latkar. Developer and manufacturer of minimally invasive cardiovascular devices. The company has 93 employees. Its Indian entity Saakshi Medtech And Panels Limited reported revenue of βΉ93.00 Cr. SMPL offers products and services including Health Care and Control Panel. Its focus areas include Industrial Goods and Manufacturing and Manufacturing Services.
Company details
The company was established in 2001 in Pune, India, within the medical devices sector. Minimally invasive cardiovascular devices are developed and manufactured, with emphasis on coronary, structural heart, and closure applications. Licenses for the commercial production of medical diagnostic X-ray equipment are held. Secure and reliable SMTP email relay services are provided for transactional email requirements.
- Market Cap₹677 Cr
SAAKSHI-SM · NSE
- Share Price₹353.00
+2.62% today
- Revenue₹116 Cr
FY 2025-26 · +25.0% YoY
- EBITDA₹22.22 Cr
Margin 19.2%
- Net Profit₹12.29 Cr
FY 2025-26 · +160.9% YoY
- P/E (TTM)57.1x
P/B 4.6x
- Employee Count93
Associated legal entities of SMPL
SMPL operates through Saakshi Medtech And Panels Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saakshi Medtech And Panels Limited Listed CIN U51909PN2009PLC133690 | Active | 25 Mar 2009 | Pune, Maharashtra | ₹93.0 Cr | 93 | 6 | View details |
Products & Services of SMPL
SMPL offers a comprehensive portfolio of products and services, including Health Care and Control Panel.
Health care products are provided for medical applications, including diagnostic equipment.
Control panels are manufactured for various industrial uses in the electrical sector.
Board of directors of Saakshi Medtech And Panels Limited (SMPL)
Saakshi Medtech And Panels Limited is the primary company behind SMPL. The board of Saakshi Medtech And Panels Limited currently have 4 directors; the longest-serving is Chitra Vijay Latkar, appointed in 2010. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chitra Vijay Latkar DIN 03291988 | Director | 26 Oct 2010 | 16 yrs | Saakshi Medtech And Panels Limited |
| Aniket Vijay Latkar DIN 03312108 | Managing Director | 21 Apr 2011 | 15 yrs 7 mo | Saakshi Medtech And Panels Limited |
| Mayuri Aniket Latkar DIN 03312077 | Whole-time director | 24 Mar 2023 | 3 yrs 7 mo | Saakshi Medtech And Panels Limited |
| Amit Yashavant Ghaisas DIN 00876472 | Director | 22 Jun 2023 | 3 yrs 4 mo | Saakshi Medtech And Panels Limited |
People of SMPL
1 people are tracked at SMPL (1 in leadership); the tracked headcount is 93.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership |
Complete people profiles for SMPL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of SMPL
SMPL is a publicly listed company on the NSE with ticker symbol SAAKSHI in India, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Oct 2023
- Listed onNSE: SAAKSHI
- Listed entitySaakshi Medtech and Panels Limited
- Exchange sectorProducer manufacturing
- ISININE0PSK01027
- Share price₹363.00 (-1.89% on the day) · 2026-10-14
- Market capitalisation₹718 Cr
- Price to earnings52.2
- EPS (diluted, trailing year)₹6.96
- Volume (last session)1,800
Financials of SMPL
Exchange-reported figures of Saakshi Medtech And Panels Limited, the listed company behind SMPL (NSE: SAAKSHI-SM).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 116 | 92.43 | 122 | 122 | 91.58 | 59.77 | 61.26 |
| Revenue growth | +25.0% | -24.2% | -0.2% | +33.3% | +53.2% | -2.4% | - |
| EBITDA | 22.22 | 10.23 | 19.66 | 20.55 | 15.64 | 5.87 | 11.08 |
| EBITDA margin | +19.2% | +11.1% | +16.1% | +16.8% | +17.1% | +9.8% | +18.1% |
| Profit before tax | 16.67 | 6.50 | 14.93 | 16.58 | 12.65 | 3.13 | 7.60 |
| Net profit | 12.29 | 4.71 | 11.30 | 12.36 | 9.36 | 2.10 | 5.80 |
| Net profit margin | +10.6% | +5.1% | +9.3% | +10.1% | +10.2% | +3.5% | +9.5% |
| EPS (βΉ) | 6.96 | 2.67 | 6.40 | 47.60 | 360.61 | 80.96 | 222.60 |
| Balance sheet | |||||||
| Total assets | - | 116 | 113 | 64.96 | 46.45 | 42.40 | 37.31 |
| Net worth | - | 98.05 | 93.34 | 42.24 | 29.86 | 20.14 | 18.03 |
| Total debt | - | 17.83 | 18.02 | 20.07 | 16.36 | 21.99 | 18.99 |
| Cash & bank | - | 3.26 | 15.50 | 3.16 | 1.30 | 2.77 | 1.74 |
| Net working capital | - | 39.58 | 47.82 | 28.04 | 17.93 | 17.97 | 12.14 |
| Cash flow | |||||||
| Cash from operations | - | 3.02 | 7.51 | 10.92 | 10.96 | 0.28 | 10.98 |
| Cash from investing | - | (14.66) | (31.27) | (11.33) | (5.48) | (0.77) | (6.47) |
| Cash from financing | - | (0.60) | 36.10 | 2.26 | (6.95) | 1.52 | (2.91) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 116 | 92.43 | 122 | 122 | 91.58 | 59.77 | 61.26 |
| Revenue growth | +25.0% | -24.2% | -0.2% | +33.3% | +53.2% | -2.4% | - |
| Other income | 0.54 | 0.57 | 0.75 | 0.14 | 0.12 | 0.45 | 0.45 |
| Total expenses | 93.29 | 82.20 | 102 | 102 | 75.94 | 53.90 | 50.18 |
| Employee cost | 0.00 | 12.86 | 12.27 | 11.15 | 8.16 | 6.30 | 6.32 |
| EBITDA | 22.22 | 10.23 | 19.66 | 20.55 | 15.64 | 5.87 | 11.08 |
| EBITDA margin | +19.2% | +11.1% | +16.1% | +16.8% | +17.1% | +9.8% | +18.1% |
| Depreciation | 4.74 | 3.89 | 3.85 | 2.65 | 1.72 | 1.70 | 1.59 |
| Interest | 1.35 | 0.41 | 1.63 | 1.46 | 1.39 | 1.49 | 2.34 |
| Profit before tax | 16.67 | 6.50 | 14.93 | 16.58 | 12.65 | 3.13 | 7.60 |
| Tax | 4.38 | 1.79 | 3.63 | 4.22 | 3.27 | 1.02 | 1.80 |
| Net profit | 12.29 | 4.71 | 11.30 | 12.36 | 9.36 | 2.10 | 5.80 |
| Net profit margin | +10.6% | +5.1% | +9.3% | +10.1% | +10.2% | +3.5% | +9.5% |
| EPS (βΉ) | 6.96 | 2.67 | 6.40 | 47.60 | 360.61 | 80.96 | 222.60 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 17.66 | 17.66 | 2.60 | 2.60 | 2.60 | 2.60 |
| Reserves & surplus | - | 80.39 | 75.68 | 39.64 | 27.26 | 17.54 | 15.43 |
| Shareholders' funds (net worth) | - | 98.05 | 93.34 | 42.24 | 29.86 | 20.14 | 18.03 |
| Secured loans | - | 14.05 | 15.04 | 16.32 | 15.87 | 21.41 | 18.22 |
| Unsecured loans | - | 3.78 | 2.98 | 3.75 | 0.49 | 0.58 | 0.77 |
| Total debt | - | 17.83 | 18.02 | 20.07 | 16.36 | 21.99 | 18.99 |
| Total liabilities | - | 116 | 113 | 64.96 | 46.45 | 42.40 | 37.31 |
| Assets | |||||||
| Gross block | - | 83.73 | 81.93 | 50.21 | 39.07 | 33.29 | 32.48 |
| Net block | - | 60.08 | 62.17 | 34.30 | 25.79 | 21.64 | 22.48 |
| Capital work in progress | - | 13.20 | 0.00 | 0.00 | 0.13 | 0.16 | 0.10 |
| Investments | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.28 |
| Inventories | - | 20.41 | 21.65 | 23.67 | 13.36 | 10.57 | 7.73 |
| Sundry debtors | - | 21.88 | 17.31 | 22.96 | 17.47 | 14.67 | 10.43 |
| Cash & bank balances | - | 3.26 | 15.50 | 3.16 | 1.30 | 2.77 | 1.74 |
| Loans & advances | - | 8.88 | 11.03 | 6.32 | 4.33 | 2.82 | 2.77 |
| Total current assets | - | 54.43 | 65.49 | 56.11 | 36.46 | 30.83 | 22.67 |
| Total current liabilities | - | 14.85 | 17.67 | 28.07 | 18.53 | 12.86 | 10.53 |
| Net working capital | - | 39.58 | 47.82 | 28.04 | 17.93 | 17.97 | 12.14 |
| Total assets | - | 116 | 113 | 64.96 | 46.45 | 42.40 | 37.31 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 15.50 | 3.16 | 1.30 | 2.77 | 1.74 | 0.14 |
| Net cash from operating activities | - | 3.02 | 7.51 | 10.92 | 10.96 | 0.28 | 10.98 |
| Net cash from investing activities | - | (14.66) | (31.27) | (11.33) | (5.48) | (0.77) | (6.47) |
| Net cash from financing activities | - | (0.60) | 36.10 | 2.26 | (6.95) | 1.52 | (2.91) |
| Net change in cash | - | (12.23) | 12.34 | 1.85 | (1.46) | 1.02 | 1.60 |
| Closing cash | - | 3.26 | 15.50 | 3.16 | 1.30 | 2.77 | 1.74 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +25.0% | -24.2% | -0.2% | +33.3% | +53.2% | -2.4% | - |
| EBITDA growth | +117.2% | -48.0% | -4.3% | +31.4% | +166.4% | -47.0% | - |
| PBT growth | +156.5% | -56.5% | -10.0% | +31.1% | +304.2% | -58.8% | +9997.0% |
| Net income growth | +160.9% | -58.3% | -8.6% | +32.1% | +345.7% | -63.8% | - |
| Revenue CAGR (3Y) | -1.8% | +0.3% | +26.8% | +25.8% | - | - | - |
| EBITDA CAGR (3Y) | +2.6% | -13.2% | +49.6% | +22.9% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +10.6% | +5.1% | +9.3% | +10.1% | +10.2% | +3.5% | +9.5% |
| Return on capital employed | - | +6.0% | +18.6% | +32.4% | +31.6% | +11.6% | +26.6% |
| Return on net worth | - | +4.9% | +16.7% | +34.3% | +37.5% | +11.0% | +32.1% |
| Debt / equity | - | 0.19 | 0.28 | 0.51 | 0.77 | 1.07 | 1.02 |
| Long-term debt / equity | - | 0.15 | 0.16 | 0.20 | 0.30 | 0.41 | -0.38 |
| Interest cover | 7.72 | 6.47 | 10.31 | 8.16 | 9.99 | 35.73 | 24.66 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.30 | 2.16 | 3.21 | 2.53 | 1.82 | 1.89 |
| Inventory turnover | - | 5.12 | 6.30 | 7.74 | 7.65 | 6.53 | 7.92 |
| Debtors turnover | - | 5.50 | 7.09 | 7.09 | 5.70 | 4.76 | 5.87 |
| EPS (βΉ) | 6.96 | 2.67 | 6.40 | 47.60 | 360.61 | 80.96 | 222.60 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 55.53 | 52.86 | 162.46 | 1,148.37 | 774.56 | 693.60 |
Web traffic of SMPL
The website of SMPL (smtpl.co) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 40.4% vs previous month
Top companies in Contract & Outsourced Manufacturing
3 companies that operate in the same segment as SMPL (Contract & Outsourced Manufacturing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Industrial components, mould bases, and storage solutions are manufactured globally. | 1986 | Coimbatore, Tamil Nadu, India | USD 28 M | USD 853.09 M | 43 | |
Single- and three-phase transformers are manufactured in Mumbai. | 1993 | Mumbai, Maharashtra, India | USD 114.37 M | 618 | ||
Apparel and clothing are manufactured and exported on contract. | 1979 | Bengaluru, Karnataka, India | USD 400 M | 40,280 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Smpl
Complete news archive for SMPL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SMPL
SMPL was founded in 2001.
SMPL is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
SMPL has 93 employees.
The primary company behind SMPL, Saakshi Medtech And Panels Limited, reported revenue of βΉ93.00 Cr for FY 2025, down 24% year on year.
The company was established in 2001 in Pune, India, within the medical devices sector. Minimally invasive cardiovascular devices are developed and manufactured, with emphasis on coronary, structural heart, and closure applications. Licenses for the commercial production of medical diagnostic X-ray equipment are held. Secure and reliable SMTP email relay services are provided for transactional email requirements.
SMPL offers Health Care and Control Panel.
Yes, SMPL is publicly traded on NSE under the ticker symbol SAAKSHI.
SMPL operates through Saakshi Medtech And Panels Limited.
The legal entities of SMPL currently have 5 directors, including Chitra Vijay Latkar, Aniket Vijay Latkar, Mayuri Aniket Latkar and others.
